{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:50:33Z","timestamp":1791996633393,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["491715122 \\u2013 microBone"],"award-info":[{"award-number":["491715122 \\u2013 microBone"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbo.2026.100792","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:12:43Z","timestamp":1785510763000},"page":"100792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro"],"prefix":"10.1016","volume":"60","author":[{"given":"M.","family":"Hein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mei\u00dfner-Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kriukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kuric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Docheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rudert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Horas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2026.100792_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1051\/sicotj\/2017028","article-title":"Osteosarcoma: a comprehensive review","volume":"4","author":"Misaghi","year":"2018","journal-title":"SICOT J."},{"key":"10.1016\/j.jbo.2026.100792_bb0010","series-title":"Pediatric and Adolescent Osteosarcoma","first-page":"3","article-title":"The epidemiology of osteosarcoma","author":"Ottaviani","year":"2010"},{"issue":"13","key":"10.1016\/j.jbo.2026.100792_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5435\/JAAOS-D-20-01188","article-title":"Chondrosarcoma","volume":"29","author":"Weinschenk","year":"2021","journal-title":"J. Am. Acad. Orthop. Surg."},{"issue":"8","key":"10.1016\/j.jbo.2026.100792_bb0020","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/jcm10081685","article-title":"Ewing sarcoma-diagnosis, treatment, clinical challenges and future perspectives","volume":"10","author":"Zollner","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.jbo.2026.100792_bb0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00132-011-1866-7","article-title":"Primary malignant bone tumors","volume":"40","author":"von Eisenhart-Rothe","year":"2011","journal-title":"Orthopade"},{"issue":"1","key":"10.1016\/j.jbo.2026.100792_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.semdp.2011.02.002","article-title":"Primary malignant bone tumors--recent developments","volume":"28","author":"Hameed","year":"2011","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.jbo.2026.100792_bb0035","doi-asserted-by":"crossref","unstructured":"J.W. Pike, M.B. Meyer, S.M. Lee, M. Onal, N.A. Benkusky, Genome-Wide Perspectives on Vitamin D Receptor\u2013Mediated Control of Gene Expression in Target Cells, in: D. Feldman (Ed.), Vitamin D, Academic Press, 2018, pp. 141\u2013174.","DOI":"10.1016\/B978-0-12-809965-0.00009-4"},{"key":"10.1016\/j.jbo.2026.100792_bb0040","series-title":"Vitamin D","first-page":"81","article-title":"Cyp24a1","author":"St-Arnaud","year":"2018"},{"issue":"2","key":"10.1016\/j.jbo.2026.100792_bb0045","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5386","article-title":"CYP11A1-derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas","volume":"61","author":"Slominski","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.jbo.2026.100792_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103072","article-title":"Differential and overlapping effects of 20,23(OH)2D3 and 1,25(OH)2D3 on gene expression in human epidermal keratinocytes: identification of AhR as an alternative receptor for 20,23(OH)2D3","volume":"19","author":"Slominski","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jbo.2026.100792_bb0055","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1096\/fj.13-242040","article-title":"RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D","volume":"28","author":"Slominski","year":"2014","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.jbo.2026.100792_bb0060","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/ijc.22058","article-title":"CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer","volume":"119","author":"Parise","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbo.2026.100792_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2015.11.008","article-title":"CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer","volume":"50","author":"Sun","year":"2016","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.jbo.2026.100792_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.29717","article-title":"Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy","volume":"138","author":"Hobaus","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.jbo.2026.100792_bb0075","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3892\/or.2016.5072","article-title":"CYP24A1-induced vitamin D insufficiency promotes breast cancer growth","volume":"36","author":"Osanai","year":"2016","journal-title":"Oncol. Rep."},{"issue":"13","key":"10.1016\/j.jbo.2026.100792_bb0080","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/cancers13133111","article-title":"Knocking out the vitamin D receptor enhances malignancy and decreases responsiveness to vitamin D3 hydroxyderivatives in human melanoma cells","volume":"13","author":"Podgorska","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.jbo.2026.100792_bb0085","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.3744","article-title":"Loss of the vitamin D receptor in human breast Cancer cells promotes epithelial to mesenchymal cell transition and skeletal colonization","volume":"34","author":"Horas","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.jbo.2026.100792_bb0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07357907.2017.1351985","article-title":"High prevalence of vitamin D deficiency in patients with bone Tumors","volume":"35","author":"Horas","year":"2017","journal-title":"Cancer Investig."},{"key":"10.1016\/j.jbo.2026.100792_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100329","article-title":"Does vitamin D deficiency predict tumour malignancy in patients with bone tumours? Data from a multi-center cohort analysis","volume":"25","author":"Horas","year":"2020","journal-title":"J. Bone Oncol."},{"issue":"6","key":"10.1016\/j.jbo.2026.100792_bb0100","first-page":"3743","article-title":"Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts","volume":"24","author":"Pautke","year":"2004","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.jbo.2026.100792_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/gcc.20717","article-title":"Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort","volume":"49","author":"Ottaviano","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"issue":"22","key":"10.1016\/j.jbo.2026.100792_bb0110","first-page":"7242","article-title":"Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues","volume":"50","author":"Sano","year":"1990","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jbo.2026.100792_bb0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4049\/jimmunol.139.1.166","article-title":"Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGE2 production by human chondrosarcoma cells","volume":"139","author":"Merluzzi","year":"1987","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jbo.2026.100792_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-44110-6","article-title":"Vitamin D receptor (VDR) expression in osteosarcoma and its association with histological subtypes and metastasis","volume":"16","author":"Baly","year":"2026","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jbo.2026.100792_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4781(95)00060-T","article-title":"Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements","volume":"1263","author":"Chen","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"35","key":"10.1016\/j.jbo.2026.100792_bb0130","doi-asserted-by":"crossref","first-page":"21881","DOI":"10.1016\/S0021-9258(18)45821-8","article-title":"The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer","volume":"265","author":"Ozono","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jbo.2026.100792_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2005.11.039","article-title":"Vitamin D signaling is modulated on multiple levels in health and disease","volume":"248","author":"Ebert","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jbo.2026.100792_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.992666","article-title":"PTH, FGF-23, klotho and vitamin D as regulators of calcium and phosphorus: genetics, epigenetics and beyond","volume":"13","author":"Portales-Castillo","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"Pt A","key":"10.1016\/j.jbo.2026.100792_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsbmb.2013.09.012","article-title":"Vitamin D and DBP: the free hormone hypothesis revisited","volume":"144","author":"Chun","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"13","key":"10.1016\/j.jbo.2026.100792_bb0150","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","article-title":"Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells","volume":"20","author":"van Driel","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jbo.2026.100792_bb0155","series-title":"Vitamin D","first-page":"117","article-title":"Regulation of renal and extrarenal 1\u03b1-hydroxylase","author":"Larner","year":"2018"},{"key":"10.1016\/j.jbo.2026.100792_bb0160","series-title":"Vitamin D","first-page":"635","article-title":"Pharmacology and pharmacokinetics","author":"Schoenmakers","year":"2018"},{"issue":"2","key":"10.1016\/j.jbo.2026.100792_bb0165","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/en.2004-1116","article-title":"Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse","volume":"146","author":"Masuda","year":"2005","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jbo.2026.100792_bb0170","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/1078-0432.CCR-10-1789","article-title":"CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3\u20134","key":"10.1016\/j.jbo.2026.100792_bb0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0960-0760(95)00218-9","article-title":"Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption","volume":"55","author":"van den Bemd","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jbo.2026.100792_bb0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0006-2952(03)00283-1","article-title":"Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein","volume":"66","author":"Ryhanen","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.jbo.2026.100792_bb0185","first-page":"3471","article-title":"The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach","volume":"29","author":"Kriebitzsch","year":"2009","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.jbo.2026.100792_bb0190","first-page":"2304","article-title":"Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy","volume":"60","author":"Diaz","year":"2000","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.jbo.2026.100792_bb0195","first-page":"667","article-title":"Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer","volume":"1","author":"Guzey","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"1\u20133","key":"10.1016\/j.jbo.2026.100792_bb0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsbmb.2008.09.004","article-title":"Species difference exists in the effects of 1alpha,25(OH)(2)D(3) and its analogue 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D(3) (2MD) on osteoblastic cells","volume":"112","author":"Li","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jbo.2026.100792_bb0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cc.5.4.2467","article-title":"AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells","volume":"5","author":"Zhang","year":"2006","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.jbo.2026.100792_bb0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00008390-200308000-00002","article-title":"Antiapoptotic action of 1alpha,25-dihydroxyvitamin D3 in primary human melanocytes","volume":"13","author":"Sauer","year":"2003","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.jbo.2026.100792_bb0215","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1359\/jbmr.080326","article-title":"Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K\/AKT signaling in osteoblasts","volume":"23","author":"Zhang","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.jbo.2026.100792_bb0220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ceb.2011.12.004","article-title":"Directed cell invasion and migration during metastasis","volume":"24","author":"Bravo-Cordero","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jbo.2026.100792_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.876397","article-title":"Vitamin D reduces thyroid Cancer cells migration independently from the modulation of CCL2 and CXCL8 chemokines secretion","volume":"13","author":"Coperchini","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.jbo.2026.100792_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01753887","article-title":"1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro","volume":"12","author":"Hansen","year":"1994","journal-title":"Clin. Exp. Metastasis"},{"issue":"1\u20132","key":"10.1016\/j.jbo.2026.100792_bb0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0303-7207(00)00226-4","article-title":"1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration","volume":"164","author":"Sung","year":"2000","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:31:09Z","timestamp":1791995469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137426000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S2212137426000540"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100792","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100792"}}